Expected difference in formulations [Power / Sample Size]

posted by Ahmed meeran – 2006-11-01 13:37 (7169 d 17:20 ago) – Posting: # 351
Views: 14,507

Dear Dr. Helmut,

Even if we account for CV as you have discussed, How could we account for the difference in the formulation for test and reference to calculate the sample size.

n > [t(alpha, 2n-2) + t(beta, 2n-2)]2 [CV/(20-eta)]2,
where eta = 100 x theta/µR = 100 x (µT - µR)/ µR

EQN is referred from ANVISA.

With regards,

D.Ahmed

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
165 visitors (0 registered, 165 guests [including 14 identified bots]).
Forum time: 07:57 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5